![]() |
CZECH MEDICAL ASSOCIATION J. Ev. PURKYNĚ |
Journals - Article | |
![]() |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Česky / Czech version | Vnitř. Lék., 47, 2001, No. 2, p. 92-98 |
High-dosage Chemotherapy with Support of Autologous Haematopoietic
Cells in the Treatment of Multiple Myeloma - Review of Contemporary Possibilities Ráčil Z., Adam Z., Hájek R.,Tomíška M., Krejčí M., Křivanová A., Höklová J., Doubek M., Mayer J., Vorlíček J. Interní hematoonkologická klinika FN Brno, pracoviště Bohunice, přednosta prof. MUDr. J. Vorlíček, CSc. |
|
Summary: High-dosage chemotherapy with autologous transplantation of haematopietic stem cells prolonged the survival of patients with multiple myeloma as compared with results of standard chemotherapy, on average by 1.5 years. Nowadays this method is the standard treatment for suitable
patients. Findings assembled recently are discussed by the authors.
|
|
Order this issue
|
BACK TO CONTENTS | ||
| HOME PAGE | CODE PAGE | CZECH VERSION | |
© 1998 - 2008 CZECH MEDICAL ASSOCIATION J. E. PURKYNĚ |
Created by: NT Servis, s.r.o., hosted by P.E.S. consulting, s.r.o. |
WEBMASTER |